Skip to main content
HUALAN GROUP CO.,LTD. logo

HUALAN GROUP CO.,LTD. — Investor Relations & Filings

Ticker · 301027 ISIN · CNE100004MH7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2022-12-16 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 301027

About HUALAN GROUP CO.,LTD.

https://www.gxhl.com

Hualan Group Co., Ltd. specializes in the research, development, and manufacturing of primary pharmaceutical packaging materials. The company's core product portfolio includes high-quality butyl rubber stoppers, aluminum-plastic combination caps, and plastic components designed for injectable medications and infusion sets. These products are engineered to ensure drug stability and compatibility, meeting international quality standards such as GMP. Serving a global clientele of pharmaceutical manufacturers, the group focuses on advanced material science and precision manufacturing to provide secure sealing solutions for vaccines, antibiotics, and blood products. By integrating R&D with large-scale production capabilities, the company maintains a significant role in the pharmaceutical supply chain, emphasizing safety and reliability in drug delivery systems.

Recent filings

Filing Released Lang Actions
关于调整公司2022年限制性股票激励计划激励对象名单及授予数量的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding adjustments to the company's 2022 restricted stock incentive plan, including changes to the list of incentive recipients and the number of shares granted. It details board and supervisory approvals, legal opinions, and independent financial advisor opinions related to the stock incentive plan. The content focuses on management decisions about stock incentives and related approvals rather than financial results, earnings, or regulatory filings. It is not a full financial report, earnings release, or proxy solicitation. The document is a formal announcement of changes in management incentive plans, which falls under Board/Management Information (MANG) as it relates to management decisions and governance on stock incentives.
2022-12-16 Chinese
德恒上海律师事务所关于华蓝集团股份公司2022年限制性股票激励计划调整及授予相关事项的法律意见
Capital/Financing Update Classification · 95% confidence The document is a legal opinion issued by a law firm regarding the adjustment and granting of a 2022 restricted stock incentive plan for a company. It contains detailed legal analysis, references to regulatory compliance, approval processes, and specific terms of the stock incentive plan. It is not a financial report, earnings release, or management discussion. It is also not a simple announcement or certification but a comprehensive legal opinion related to a capital/financing activity (stock incentive plan). Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length (9387 characters) and content confirm it is a substantive legal opinion rather than a brief announcement or regulatory filing.
2022-12-16 Chinese
独立董事关于第四届董事会第十次会议相关事项的独立意见
Regulatory Filings Classification · 95% confidence The document is an independent director's opinion on matters discussed at the 10th meeting of the 4th board of directors of 华蓝集团股份公司. It discusses adjustments to a 2022 restricted stock incentive plan, including the list of incentive recipients and the granting of restricted stock. The document references compliance with company law, securities law, and stock exchange listing rules, and confirms the legality and appropriateness of the stock incentive plan adjustments and grants. The document is relatively short (1484 characters) and is a formal opinion or statement related to board decisions on stock incentives, not a full report or financial statement. It does not contain financial data or detailed financial analysis, nor is it a report publication announcement. It is a regulatory or compliance-related filing expressing independent directors' opinions on board matters, which fits best under Regulatory Filings (RNS).
2022-12-16 Chinese
第四届监事会第八次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the eighth meeting of the fourth Supervisory Board of Huazhan Group Co., Ltd. It details the meeting's convening, the voting results, and the approval of adjustments to the 2022 restricted stock incentive plan and the granting of restricted stocks to incentive recipients. The document is an official meeting resolution announcement rather than a full report or financial statement. It does not contain financial data or detailed management discussion but focuses on governance and supervisory board decisions related to stock incentives. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or decisions by company boards or senior management bodies.
2022-12-16 Chinese
上海信公轶禾企业管理咨询有限公司关于华蓝集团股份公司2022年限制性股票激励计划授予相关事项之独立财务顾问报告
Capital/Financing Update Classification · 95% confidence The document is titled as an "Independent Financial Advisor Report" regarding the 2022 restricted stock incentive plan of Huazhan Group Co., Ltd. It contains detailed information about the stock incentive plan, including approval procedures, grant details, conditions, and the advisor's verification opinions. The content is focused on the stock incentive plan and the independent financial advisor's review and opinion on it. This type of document is a specialized advisory report related to capital/financing activities, specifically stock incentive plans. It is not a general annual or interim report, nor is it a simple announcement or certification. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length (6348 characters) and detailed content confirm it is a full report, not just an announcement or certification.
2022-12-16 Chinese
第四届董事会第十次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 10th meeting of the 4th Board of Directors of Huazhan Group Co., Ltd. It details the meeting date, attendance, and the voting results on specific agenda items related to adjustments in the 2022 restricted stock incentive plan. The content focuses on board decisions and approvals rather than financial results, audit opinions, or shareholder voting outcomes. It does not contain financial statements or detailed financial analysis, nor is it a transcript or presentation. The document is clearly a Board/Management Information announcement about board meeting resolutions and management decisions.
2022-12-16 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.